Glucagon-like peptide-1 receptor agonists in liver transplant recipients with diabetes: changes in glucose control and cardiometabolic risk factors

Glucagon-like peptide-1 receptor agonists in liver transplant recipients with diabetes: changes in glucose control and cardiometabolic risk factors

IntroductionData about efficacy and safety of GLP1 receptor agonists in liver-transplanted patients are lacking.MethodsAmong a population of liver-transplanted individuals with diabetes, we evaluated 68 patients before, 6, 12 and 18 months after starting a GLP1RA-based therapy, as add on to metformi...

Full description

Saved in:
Bibliographic Details
Main Authors: Valeria Grancini, Irene Cogliati, Gianfranco Alicandro, Andreina Oliverio, Clara Di Benedetto, Alessia Gaglio, Pietro Lampertico, Veronica Resi, Emanuela Orsi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Endocrinology
Subjects:
glucagon-like peptide-1 receptor agonists
liver transplantation
diabetes mellitus
GLP1-RAs
post transplant diabetes mellitus
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1586941/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2025.1586941/full

Similar Items